apremilast
SpainDrugs containing this active substance
-
It is used to treat adults with active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and Behçet's disease (for oral ulcers). It is also prescribed to children and adolescents aged 6 years or older weighing at least 20 kg for moderate to severe plaque psoriasis.
Form: tablets, film-coated
Active substance Dosage apremilast 10 mg apremilast 20 mg apremilast 30 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat adults with active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and Behçet's disease (to treat mouth ulcers). It is also used in children and adolescents aged 6 years or older weighing at least 20 kg for moderate to severe plaque psoriasis.
Form: tablets, film-coated
Active substance Dosage apremilast 30 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used in adults to treat active psoriatic arthritis (if other medicines do not work), moderate to severe chronic plaque psoriasis, and to reduce mouth ulcers in Behçet's disease.
Form: tablets, film-coated
Active substance Dosage apremilast 10 mg apremilast 20 mg apremilast 30 mg Manufacturer: Glenmark Arzneimittel Gmbh
-
It is used in adults to treat active psoriatic arthritis, moderate-to-severe chronic plaque psoriasis, and Behçet's disease (specifically for oral ulcers).
Form: tablets, film-coated
Active substance Dosage apremilast 30 mg Manufacturer: Glenmark Arzneimittel Gmbh
-
It is used to treat adults with active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and Behçet's disease (to treat mouth ulcers). It is also used in children and adolescents aged 6 years or older weighing at least 20 kg for moderate to severe plaque psoriasis.
Form: tablets, film-coated
Active substance Dosage apremilast 10 mg apremilast 20 mg apremilast 30 mg Manufacturer: Stada Arzneimittel Ag
-
It is used to treat adults with active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and Behçet's disease (specifically for oral ulcers). It is also used in children and adolescents aged 6 years or older with moderate to severe plaque psoriasis, provided their doctor deems it appropriate.
Form: tablets, film-coated
Active substance Dosage apremilast 30 mg Manufacturer: Stada Arzneimittel Ag
-
It is used to treat adults with active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and to treat mouth ulcers in people with Behçet's disease.
Form: tablets, film-coated
Active substance Dosage apremilast 10 mg apremilast 20 mg apremilast 30 mg Manufacturer: Tarbis Farma S.L.
-
It is used to treat adults with active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and to treat mouth ulcers in people with Behçet's disease.
Form: tablets, film-coated
Active substance Dosage apremilast 30 mg Manufacturer: Tarbis Farma S.L.
-
It is used to treat adults with active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and Behçet's disease (to treat mouth ulcers). It is also prescribed to children and adolescents aged 6 years or older weighing at least 20 kg for moderate to severe plaque psoriasis.
Form: tablets, film-coated
Active substance Dosage apremilast 30 mg apremilast 20 mg apremilast 10 mg Manufacturer: Teva B.V.
-
It is used to treat adults with active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and Behçet's disease (to treat mouth ulcers). It is also prescribed in children and adolescents aged 6 years or older with moderate to severe plaque psoriasis, provided their doctor deems it appropriate.
Form: tablets, film-coated
Active substance Dosage apremilast 30 mg Manufacturer: Teva B.V.